Interactions of Medicine and Exercise With Meal Timing
Launched by UNIVERSITY OF CASTILLA-LA MANCHA · Jul 15, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the timing of taking medications and eating meals can affect the health of people with metabolic syndrome, a condition that includes issues like high blood pressure, insulin resistance, and obesity. The researchers want to see if exercising after eating or on an empty stomach, along with adjusting when participants take their medications, can help improve these health challenges. They will also explore how the time of day affects these outcomes.
To join the study, participants should be between 65 and 74 years old and have been diagnosed with metabolic syndrome. However, those with certain health problems, such as heart disease or severe lung issues, can't participate. If you join the trial, you can expect to engage in exercise training while following specific guidelines about when to eat and take your medication. This study is currently recruiting participants, and the findings could help improve treatment strategies for metabolic syndrome in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Metabolic syndrome patients diagnosed according to The International diabetes federation consensus of 2009 (Alberti, et al., Circulation).
- Exclusion Criteria:
- • Cardiovascular disease or musculo-skeletal that prevents them from being able to perform intense exercise.
- • Respiratory failure
- • Liver o renal disease
- • Pregnancy
About University Of Castilla La Mancha
The University of Castilla-La Mancha is a prominent academic institution dedicated to advancing research and innovation in various fields, including health sciences. With a commitment to fostering interdisciplinary collaboration, the university engages in groundbreaking clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Its research initiatives are supported by a robust network of experts and cutting-edge facilities, positioning the university as a leading sponsor in clinical research within the region. Through its rigorous ethical standards and dedication to scientific excellence, the University of Castilla-La Mancha strives to contribute significantly to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toledo, , Spain
Patients applied
Trial Officials
RICARDO M Mora-Rodriguez, PhD
Principal Investigator
University of Castilla-La Mancha
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials